Bone SPECT/CT Tumor Burden Biomarkers Predict Survival in Metastatic Prostate Cancer
Volumetric tumor burden measurements derived from quantitative bone SPECT/CT significantly predict overall survival in metastatic castration-resistant prostate cancer patients undergoing ...










